Prilenia

Biotechnology Research · 11 Employees
Phone Number: 972775558482
Email Address: medinfo@prilenia.com
  • Overview
  • Job Postings
  • Employees
Access 25 Verified Employees Profiles for PrileniaUnlock Free Contacts Now
About
Prilenia is a clinical-stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders. Our lead asset is Pridopidine, a first-in-class oral drug candidate with an established safety profile and potential in multiple movement disorders and neurodegenerative diseases affecting adults and children. Pridopidine is currently being evaluated for the treatment of Huntington’s disease in our global Phase 3 PROOF-HD trial, and for the treatment of ALS in the Phase 2/3 HEALEY platform trial. The company is led by Dr. Michael Hayden, MD, PhD, the founder of five biotech companies and previous President of Global R&D and Chief Scientific Officer at Teva. Michael has directed the development of multiple innovative drug products, leading to 35 approvals between 2012-2018. The Company is based in Naarden, the Netherlands, Herzliya, Israel and Boston, MA in the U.S.
Year Founded
2018
Social Media
LinkedinTwitter
Industry
Biotechnology Research
HQ Location
Boston, Massachusetts, US
Keywords
--
Location
3
  • Boston, Massachusetts, US
  • Herzliya, Israel, IL
  • Naarden, NL

Email Formats

Sign up for free credits and discover verified email addresses of Prilenia
FormatExamples
first + last
andywarhol@prilenia.com
first_initial + last
awarhol@prilenia.com
first + last_initial
andyw@prilenia.com
first
andy@prilenia.com
last
warhol@prilenia.com
Get Verified Emails for 25 Prilenia Employees

Frequently Asked Questions

Learn More about Prilenia

Similar Companies

Biotechnology Research

Get key business info for Prilenia and other 100M companies. Start your seach.

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.